HHS Engages Sanofi’s Recombinant Technology for COVID-19 Vaccine

HHS Engages Sanofi’s Recombinant Technology for COVID-19 Vaccine U.S. Department of Health and Human Services Washington, D.C. February 18, 2020 Racing to develop a vaccine against the 2019 COVID-19, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has engaged Sanofi Pasteur, the vaccines global business unit ...
Read More»
Show More ∨